Biomune Co Information

Biomune Company is committed to research, development, manufacturing, marketing and servicing the global animal health industry with innovative, safe and efficacious vaccines to promote and enhance the welfare and performance of food-producing and companion animals. Biomune Company is a leading U.S. manufacturer of vaccines and bacterins for the animal health industry. Since its inception in 1988, the company's rapid growth has been marked by technology breakthroughs and new product introductions such as Layermune® SE , the world's first licensed Salmonella enteritidis vaccine for poultry that is considered the world's standard. Biomune has achieved a leadership position by developing disease control innovations such as the world's first recombinant laryngotracheitis (LT) vaccine for poultry and the first bacterin for Mycoplasma mastitis in cattle. In addition, Biomune is the world-leading producer of vaccines for psittacine birds, pigeons and canaries.